Abstract
BackgroundThe evolution of bulk and spatial Omics technologies coincides with a need for novel biomarkers in clinical studies for diagnostics, prognostics, agnostics, and/or mechanisms of action. Cerba Research is dedicated...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
